SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-23-000118
Filing Date
2023-12-12
Accepted
2023-12-12 16:35:24
Documents
15
Period of Report
2023-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PFIZER 8-K DECEMBER 7 2023 pfe-20231207.htm   iXBRL 8-K 41858
2 EX-99.1 pr121223ex991.htm EX-99.1 21248
7 pfizerlogoa.jpg GRAPHIC 38679
  Complete submission text file 0000078003-23-000118.txt   287962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20231207.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20231207_def.xml EX-101.DEF 15360
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20231207_lab.xml EX-101.LAB 30340
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20231207_pre.xml EX-101.PRE 16027
9 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20231207_htm.xml XML 4273
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 231481667
SIC: 2834 Pharmaceutical Preparations